Nextech Crossover I GP S.a. r.l. 13D and 13G filings for Mersana Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-26 4:29 pm Unchanged | 2024-12-20 | 13G | Mersana Therapeutics, Inc. MRSN | Nextech Crossover I GP S.a. r.l. | 482,690 10.400% | 0 (Unchanged) | Filing |
| 2024-11-14 5:45 pm Purchase | 2024-09-30 | 13G | Mersana Therapeutics, Inc. MRSN | Nextech Crossover I GP S.a. r.l. | 482,690 9.800% | 232,736 (+93.11%) | Filing |
| 2024-05-17 08:26 am Purchase | 2024-05-14 | 13G | Mersana Therapeutics, Inc. MRSN | Nextech Crossover I GP S.a. r.l. | 249,954 5.100% | 249,954 (New Position) | Filing |